Results 81 to 90 of about 67,803 (296)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost [PDF]

open access: yes, 2010
Gregory Katz1, Clark L Springs2, E Randy Craven3, Michela Montecchi-Palmer41Huron Ophthalmology, Ypsilanti, MI, USA; 2Indiana University Eye Care, Indianapolis, IN, USA; 3Specialty Eye Care, Denver, CO, USA; 4Alcon Research Ltd., Fort Worth, TX ...
Clark L Springs   +3 more
core  

Summary of existing surgically-induced rodent ocular hypertension models. [PDF]

open access: yes, 2018
Summary of existing surgically-induced rodent ocular hypertension models.
Nalini Rangaswamy (5460071)   +6 more
core   +1 more source

The role of central corneal thickness in the diagnosis of glaucoma

open access: yesIndian Journal of Ophthalmology, 2000
Purpose: To determine the effect of central corneal thickness (CCT) on applanation tonometry and any resultant misclassification of normals as ocular hypertension.
Thomas Ravi   +2 more
doaj  

Therapeutic problems in ocular hypertension

open access: yesIndian Journal of Ophthalmology, 1983
Sood N, Grover A, Agarwal H
doaj   +2 more sources

Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner

open access: yesAdvanced Science, EarlyView.
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang   +32 more
wiley   +1 more source

ORIGINAL STUDY Lifetime Visual Disability in Open-angle Glaucoma [PDF]

open access: yes, 2006
Purpose: To study how many of the patients with treated glaucoma or ocular hypertension go blind during their lifetime and which factors are associated with blindness.
Ocular Hypertension   +3 more
core  

Corneal Biomechanics for Ocular Hypertension, Primary Open-Angle Glaucoma, and Amyloidotic Glaucoma: A Comparative Study by Corvis ST

open access: yesClinical Ophthalmology, 2022
Nisa Silva,1 André Ferreira,1,2 Pedro Manuel Baptista,1 Ana Figueiredo,1 Rita Reis,1 Isabel Sampaio,1 João Beirão,1,3 Riccardo Vinciguerra,4,5 Pedro Menéres,1,3 Maria João Menéres1,3 1Ophthalmology Department, Centro Hospitalar Universitário do Porto ...
Silva N   +9 more
doaj  

Endogenous hypercortisolism inducing reversible ocular hypertension

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To describe the clinical findings of two patients with reversible ocular hypertension secondary to endogenous hypercortisolism. Design: Retrospective, observational case series.
Shane Griffin   +5 more
doaj   +1 more source

Mitochondrial Dysfunction Unravels the Potential Molecular Link Between Night Shift Work‐Related Circadian Disruption and Elevated Blood Pressure in Human and Mouse Models

open access: yesAdvanced Science, EarlyView.
This diagram illustrates that night shift work disrupts circadian clock genes (like CLOCK, BMAL1) in both humans and mice. This disruption leads to mitochondrial dysfunction (imbalanced fusion/fission proteins) and increased oxidative stress, which is identified as the primary mechanism ultimately causing elevated blood pressure.
Zhaoqiang Jiang   +16 more
wiley   +1 more source

The Accuracy and Clinical Application of Predictive Models for Primary Open-Angle Glaucoma in Ocular Hypertensive Individuals [PDF]

open access: yes, 2008
[. . . ]   +6 more
core   +3 more sources

Home - About - Disclaimer - Privacy